{"id":"atorvastatin-amlodipine-perindopril","brandName":"Atorvastatin, Amlodipine, Perindopril","genericName":"Atorvastatin, Amlodipine, Perindopril","companyId":"charles-university-czech-republic","companyName":"Charles University, Czech Republic","phase":"marketed","status":"active","modality":"Small molecule","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Atorvastatin, Amlodipine, and Perindopril are a combination of drugs developed by Charles University in the Czech Republic. Atorvastatin is a statin that lowers cholesterol, Amlodipine is a calcium channel blocker used to treat hypertension and angina, and Perindopril is an ACE inhibitor used for hypertension and heart failure. The combination is not approved by the FDA but is under investigation for potential synergistic effects in managing cardiovascular diseases. The safety profile of each drug is well-established individually, but the combination's safety and efficacy require further clinical trials. The commercial potential of this combination therapy is promising, especially in markets where cardiovascular diseases are prevalent.","enrichmentLevel":3,"visitCount":0,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Atorvastatin inhibits HMG-CoA reductase to reduce LDL cholesterol synthesis. Amlodipine is a calcium channel blocker that dilates blood vessels and reduces blood pressure. Perindopril is an ACE inhibitor that reduces angiotensin II-mediated vasoconstriction and lowers blood pressure. Together, they address multiple cardiovascular risk factors.","oneSentence":"This is a fixed-dose combination of three cardiovascular agents that work together to lower cholesterol, reduce blood pressure, and improve heart function.","_ai_confidence":"high"},"administration":{},"safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Peripheral edema"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Muscle pain or myalgia"},{"rate":null,"effect":"Cough"},{"rate":null,"effect":"Fatigue"}]},"trials":[],"indications":{"approved":[{"name":"Hypertension with dyslipidemia"},{"name":"Cardiovascular disease prevention in patients requiring combination therapy"}]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}